Skip to content
Anchorcite

Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Colin Louis Masters, Gail Simms, Nicola A. Weinman, Gerd Multhaup, Benjamin McDonald, K Beyreuther

Proceedings of the National Academy of Sciences · 1985 · 4,481 citationsOpen access

doi.org/10.1073/pnas.82.12.4245Free full text

Abstract

We have purified and characterized the cerebral amyloid protein that forms the plaque core in Alzheimer disease and in aged individuals with Down syndrome. The protein consists of multimeric aggregates of a polypeptide of about 40 residues (4 kDa). The amino acid composition, molecular mass, and NH2-terminal sequence of this amyloid protein are almost identical to those described for the amyloid deposited in the congophilic angiopathy of Alzheimer disease and Down syndrome, but the plaque core proteins have ragged NH2 termini. The shared 4-kDa subunit indicates a common origin for the amyloids of the plaque core and of the congophilic angiopathy. There are superficial resemblances between the solubility characteristics of the plaque core and some of the properties of scrapie infectivity, but there are no similarities in amino acid sequences between the plaque core and scrapie polypeptides.

Cite this paper

Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B., & Beyreuther, K. (1985). Amyloid plaque core protein in alzheimer disease and down syndrome. Proceedings of the National Academy of Sciences, 82(12), 4245–4249. https://doi.org/10.1073/pnas.82.12.4245

Read it with every claim anchored

Add this paper to a project, ask questions of it, and get answers that point to the exact passage.

Start free

Related papers

  1. Clinical diagnosis of Alzheimer's disease1984
  2. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease2011
  3. The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics2002
  4. NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease2018
  5. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease2011

Metadata from OpenAlex (CC0). Citations are generated from the published record.